NCT01613729View on ClinicalTrials.gov

Efficacy and Safety Study of 5 mg and 10 mg Rosuvastatin

PHASE4UnknownINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

December 31, 2013

Conditions
Dyslipidemia
Interventions
DRUG

Rosuvastatin 5 mg

Rosuvastatin 5 mg

DRUG

Rosuvastatin 10 mg

Trial Locations (1)

1000

BSMMU, Dhaka

Sponsors

Collaborators (1)

Dhaka Medical College
All Listed Sponsors
collaborator

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER

collaborator

Dhaka Medical College

OTHER

collaborator

National Institute of Cardiovascular Diseases

UNKNOWN

lead

D16 Pharma & Biotec Ltd.

INDUSTRY

NCT01613729 - Efficacy and Safety Study of 5 mg and 10 mg Rosuvastatin | Biotech Hunter | Biotech Hunter